News
Illuminating Success: Investors & Portfolio Day
xista science ventures hosted it's much-anticipated “Investors and Portfolio Day” centered around the theme “Shaping Human and Planetary Health", attracting a diverse audience of 100 investors, funding institutions and entrepreneurs.
Syntropic Medical secures early-stage funding from xista science ventures and aws
MedTech company secures 7-figure early-stage funding from xista science ventures and Austria Wirtschaftsservice, to develop light stimulation based treatment for mental health disorders such as Major Depressive Disorder.
G.ST Antivirals reports positive Phase I trial results
G.ST Antivirals reported positive results from Phase I clinical trials on its lead programme, a nasal spray containing 2-Deoxy-D-glucose. Phase II clinical trial funding round led by xista science ventures secured over EUR 6 million.